A compound heterozygote in the NADH-cytochrome b5 reductase gene from a Chinese patient with hereditary methemoglobinemia type I

Int J Hematol. 2000 Jul;72(1):34-6.

Abstract

To elucidate the mutation in the nicotinamide adenine dinucleotide-cytochrome b5 reductase (b5R) gene from a Chinese patient with hereditary methemoglobinemia type I, we analyzed the coding sequences of b5R cDNA from the patient and from normal subjects by direct sequencing the reverse transcriptase-polymerase chain reaction (RT-PCR) products. The PCR-amplified genomic DNA fragments of the b5R gene from the patient, his mother, and normal controls were analyzed by restriction enzymes MspI and RsaI. A compound heterozygote Arg57Gln (CGG-->CAG)/Cys203Tyr (TGC-->TAC) was found in the b5R gene from the patient, and a CGG-->CAG mutant allele occurred in a chromosome inherited from his mother, while TGC-->TAC occurred in a chromosome inherited from his father. In this report, we discuss a compound heterozygote first observed in the b5R gene from a patient with hereditary methemoglobinemia type I.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Amino Acid Substitution
  • Asian People / genetics
  • Cytochrome Reductases / genetics*
  • Cytochrome-B(5) Reductase
  • DNA Mutational Analysis
  • Family Health
  • Genetic Carrier Screening*
  • Humans
  • Male
  • Methemoglobinemia / classification
  • Methemoglobinemia / genetics*
  • Point Mutation

Substances

  • Cytochrome Reductases
  • Cytochrome-B(5) Reductase